Your browser doesn't support javascript.
loading
Protective efficacy of an attenuated Mtb ΔLprG vaccine in mice.
Martinot, Amanda J; Blass, Eryn; Yu, Jingyou; Aid, Malika; Mahrokhian, Shant H; Cohen, Sara B; Plumlee, Courtney R; Larocca, Rafael A; Siddiqi, Noman; Wakabayashi, Shoko; Gardner, Michelle; Audette, Rebecca; Devorak, Anne; Urdahl, Kevin B; Rubin, Eric J; Barouch, Dan H.
Afiliación
  • Martinot AJ; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Blass E; Department of Infectious Diseases and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, United States of America.
  • Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Aid M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Mahrokhian SH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Cohen SB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Plumlee CR; Department of Immunology, Seattle Children's Research Institute, Seattle, Washington, United States of America.
  • Larocca RA; Department of Immunology, Seattle Children's Research Institute, Seattle, Washington, United States of America.
  • Siddiqi N; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Wakabayashi S; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
  • Gardner M; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
  • Audette R; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
  • Devorak A; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
  • Urdahl KB; Department of Infectious Diseases and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, United States of America.
  • Rubin EJ; Department of Immunology, Seattle Children's Research Institute, Seattle, Washington, United States of America.
  • Barouch DH; Departments of Pediatrics and Immunology, University of Washington, Seattle, Washington, United States of America.
PLoS Pathog ; 16(12): e1009096, 2020 12.
Article en En | MEDLINE | ID: mdl-33315936
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas Atenuadas / Factores de Virulencia / Vacunas contra la Tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: PLoS Pathog Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas Atenuadas / Factores de Virulencia / Vacunas contra la Tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: PLoS Pathog Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos